Bollor CEO Rejects Ackmans Universal Bid as Insufficient Potential Deal Uncertainty Looms Trump Family Personal News Donald Jr Wedding and ExWifes Health Update Could Influence Brand Perception LOW APTV ZTS Market Digest Highlights Key Sector Movers BSE and NSE Announce Market Holiday on May 28 for Bakri Id Trading Suspended Anthropic and Microsoft Explore AI Chip Collaboration Following 5 Billion Investment 73YearOld With 15 Million 401k May Face 280000 Cumulative RMD Tax Bill Inseego Corp INSG Q1 2026 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment SMR Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage Stock Barely Moves GKOS Q1 2026 Earnings Narrowerthanexpected loss fails to lift shares Immunic Inc Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Stock Holds Gains PCG Q1 2026 Earnings Earnings Beat Driven by Operational Efficiency RWAYL Q1 2026 Earnings EPS Misses Estimates but Share Price Edges Higher Tuya Inc TUYA Slides 19 as Stock Tests Key Support Levels Robin Energy Ltd RBNE Slips Toward Support as Selling Pressure Persists Gloo Holdings Inc GLOO Slides 15 as Stock Tests Key Support Near 505 ADMA Biologics Inches Higher as Stock Holds Within Established Range comScore Inc SCOR Falls 25 as Stock Approaches Key Support Anesthesiologist Assistant Prioritizes WorkLife Balance Over Potential 500K Income Sunrise Realty Trust Inc SUNS Q1 2026 Earnings EPS Surprise of 23 Drives Positive Market Response IperionX IPX Slides 324 as Traders Monitor Key Support at 3627 Teledyne Technologies TDY Q1 2026 Earnings EPS Beat Drives Modest Stock Gain SHC Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback DEFSEC Technologies Inc DFSC Q2 2024 Earnings EPS Misses Estimates Stock Rises on Strategic Outlook JBLU Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Persist UWMC Q1 2026 Earnings EPS Beat Exceeds Expectations Amid Challenging Mortgage Market NanoX Imaging Ltd NNOX Q4 2025 Earnings Significant EPS Miss Amid Ongoing Commercialization Efforts MDCX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Posts WiderthanExpected Loss